Delivery Order SPE2DR25D7064-SPE2DR26F2MVY
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,933.78 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Thrombin-JMI, a hemostatic agent used in surgical and medical applications. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 3, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $3,195 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This contract, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical procurement to support federal medical supply requirements. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established position as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,150.20 to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- This delivery order from the Defense Logistics Agency Troop Support Medical (DLA) is valued at $134.07 and awards Amerisourcebergen Drug Corp 5,000 units of Thrombin-JMI vials. The product will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by August 14, 2023 under firm fixed pricing terms. As a major provider of medical supplies to the Department of Defense, this order for a hemostatic agent supports DLA's mission to provide critical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.35 fixed-price delivery order is for the provision of 20,000 unit vials of Thrombin-JMI, a critical medical product used in surgical procedures. The contract has a period of performance through November 29, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $7,902.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product, with a performance period ending on January 31, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,895.82 on August 26, 2025, for the supply of Thrombin-JMI 5,000 units vials, with an ultimate completion date of August 27, 2025. This firm fixed price contract is non-competitive and non-set-aside, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible...